SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 406 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $400,632 | -3.8% | 3,305 | -9.1% | 0.40% | +5.5% |
| Q2 2023 | $416,280 | -17.0% | 3,635 | -0.1% | 0.38% | -25.4% |
| Q1 2023 | $501,701 | +2.9% | 3,640 | -3.3% | 0.52% | 0.0% |
| Q4 2022 | $487,610 | +13.7% | 3,763 | -3.1% | 0.52% | +11.5% |
| Q3 2022 | $429,000 | +51.6% | 3,883 | +2.9% | 0.46% | +56.6% |
| Q2 2022 | $283,000 | -7.5% | 3,773 | -3.8% | 0.30% | +28.3% |
| Q1 2022 | $306,000 | -15.0% | 3,923 | -1.8% | 0.23% | -22.6% |
| Q4 2021 | $360,000 | – | 3,993 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 290,000 | $44,066,000 | 9.14% |
| Avoro Capital Advisors LLC | 1,400,000 | $212,730,000 | 7.35% |
| NEXTHERA CAPITAL LP | 50,317 | $7,646,000 | 6.37% |
| Eventide Asset Management | 1,123,000 | $170,640,000 | 5.19% |
| RTW INVESTMENTS, LP | 604,236 | $91,814,000 | 4.90% |
| Casdin Capital, LLC | 335,000 | $50,903,250,000 | 4.76% |
| Copernicus Capital Management, LLC | 30,000 | $4,559,000 | 4.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 548,500 | $83,345,000 | 3.76% |
| Camber Capital Management LP | 500,000 | $75,975,000 | 3.54% |
| Dynamic Capital Management Ltd | 4,677 | $711,000 | 3.54% |